Transfer of Technology for Pandemic Influenza Vaccine Production in Developing CountriesSPIER, Ray.Vaccine. Supplement. 2011, Vol 29, Num 1, issn 1359-5938, 54 p.Serial Issue

Development of pandemic influenza vaccine production capacity in Viet NamHOA, L. K; HIEP, L. V; BE, L. V et al.Vaccine. Supplement. 2011, Vol 29, Num 1, issn 1359-5938, A34-A36Article

Informing decision makers: Experience and process of 15 National Immunization Technical Advisory GroupsGESSNER, Bradford D; DUCLOS, Philippe; DEROECK, Denise et al.Vaccine. Supplement. 2010, Vol 28, Num 1, issn 1359-5938, A1-A5Article

A systematic review of national immunization policy making processesBRYSON, Maggie; DUCLOS, Philippe; JOLLY, Ann et al.Vaccine. Supplement. 2010, Vol 28, Num 1, issn 1359-5938, A6-A12Article

A global look at national Immunization Technical Advisory GroupsBRYSON, Maggie; DUCLOS, Philippe; JOLLY, Ann et al.Vaccine. Supplement. 2010, Vol 28, Num 1, issn 1359-5938, A13-A17Article

National Immunization Technical Advisory Groups (NITAGs): Guidance for their establishment and strengtheningDUCLOS, Philippe.Vaccine. Supplement. 2010, Vol 28, Num 1, issn 1359-5938, A18-A25Article

The Federal Vaccination Commission in Switzerland: An officially appointed independent commission ensuring evidence-based recommendations and transparent proceduresMASSEREY SPICHER, Virginie.Vaccine. Supplement. 2010, Vol 28, Num 1, issn 1359-5938, A48-A53Article

Canada's National Advisory Committee on Immunization (NACI): Evidence-based decision-making on vaccines and immunizationISMAIL, Shainoor J; LANGLEY, Joanne M; HARRIS, Tara M et al.Vaccine. Supplement. 2010, Vol 28, Num 1, issn 1359-5938, A58-A63Article

The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP)SMITH, Jean Clare.Vaccine. Supplement. 2010, Vol 28, Num 1, issn 1359-5938, A68-A75Article

The role of the China Experts Advisory Committee on Immunization ProgramJINGSHAN ZHENG; YUQING ZHOU; HUAQING WANG et al.Vaccine. Supplement. 2010, Vol 28, Num 1, issn 1359-5938, A84-A87Article

Species-specific CD1-restricted innate immunity for the development of HIV vaccineTAKAHASHI, Hidemi.Vaccine. Supplement. 2010, Vol 28, Num 2, issn 1359-5938, B3-B7Article

HIV-1 assembly at the plasma membraneONO, Akira.Vaccine. Supplement. 2010, Vol 28, Num 2, issn 1359-5938, B55-B59Article

HIV-2 capsids distinguish high and low virus load patients in a West African community cohortONYANGO, Clayton O; LELIGDOWICZ, Aleksandra; WHITTLE, Hilton et al.Vaccine. Supplement. 2010, Vol 28, Num 2, issn 1359-5938, B60-B67Article

New emerging technologies and the intradermal route: the novel way to immunize against influenzaFALSEY, Ann R.Vaccine. Supplement. 2010, Vol 28, Num 4, issn 1359-5938, D24-D32Article

Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countriesTALBIRD, Sandra E; TAYLOR, Thomas N; KNOLL, Stefanie et al.Vaccine. Supplement. 2010, Vol 28, Num 6, issn 1359-5938, G23-G29Article

Brucellosis in the United States: Role and significance of wildlife reservoirsOLSEN, S. C.Vaccine. Supplement. 2010, Vol 28, Num 5, issn 1359-5938, F73-F76Conference Paper

Vaccination strategies for managing brucellosis in Yellowstone bisonTREANOR, John J; JOHNSON, Joseph S; WALLEN, Rick L et al.Vaccine. Supplement. 2010, Vol 28, Num 5, issn 1359-5938, F64-F72Conference Paper

LA PDC Round TableDAGAN, Ron.Vaccine. Supplement. 2009, Vol 27, Num 3, issn 1359-5938, 35 p.Conference Proceedings

Advances in the development of next-generation anthrax vaccinesFRIEDLANDER, Arthur M; LITTLE, Stephen F.Vaccine. Supplement. 2009, Vol 27, Num 4, issn 1359-5938, D28-D32Article

Clostridium perfringens vaccinesTITBALL, Richard W.Vaccine. Supplement. 2009, Vol 27, Num 4, issn 1359-5938, D44-D47Article

PlagueWILLIAMSON, E. D.Vaccine. Supplement. 2009, Vol 27, Num 4, issn 1359-5938, D56-D60Article

Hospital-based surveillance and molecular epidemiology of rotavirus infection in Taiwan, 2005―2007WU, F. T; LIANG, S. Y; YANG, C. F et al.Vaccine. Supplement. 2009, Vol 27, Num 5, issn 1359-5938, F50-F54Article

Use of intravenous fluids in Hong Kong children hospitalised for diarrhoea and relationship to severity and aetiologyCHOW, C. M; CHOI, Kai; NELSON, E. Anthony S et al.Vaccine. Supplement. 2009, Vol 27, Num 5, issn 1359-5938, F55-F60Article

Human rotavirus genotypes in hospitalized children, South Korea, April 2005 to March 2007LEE, S. Y; HONG, S. K; MA, S. H et al.Vaccine. Supplement. 2009, Vol 27, Num 5, issn 1359-5938, F97-F101Article

The burden of hospitalised rotavirus infections in FijiJENNEY, Adam; TIKODUADUA, Lisi; BUADROMO, Eka et al.Vaccine. Supplement. 2009, Vol 27, Num 5, issn 1359-5938, F108-F111Article